EGFR and obesity due to melanocortin 4 receptor deficiency: In recent studies we showed that deletion of VSMC-EGFR mitigated T2DM/obesity-induced vascular functional, structural and transcriptome alterations drastically in vivo26, using a knock out mouse model with inducible deletion of the EGFR in VSMC12,27.